Olaparib in Patients With Solid Tumors With ATM Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Daniel R Carrizosa, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Deepti Behl, Bamidele Adesunloye, Evan Pisick, Kathleen W Beekman, Efrat Dotan, Mehmet Akce, Olatunji B Alese, Vaibhav Sahai, Kelsey A Klute, Jeanny B Aragon-Ching, Kathrine A Cooper